Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer EDITORIAL COMMENT
No Thumbnail Available
Authors
Burger, Robert A.
Brady, Mark F.
Bookman, Michael A.
Fleming, Gini F.
Monk, Bradley J.
Huang, Helen
Mannel, Robert S.
Homesley, Howard D.
Fowler, Jeffrey
Greer, Benjamin E.
Issue Date
2012
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Burger, Robert A.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Monk, Bradley J.; Huang, Helen; Mannel, Robert S.; Homesley, Howard D.; Fowler, Jeffrey; Greer, Benjamin E.; Boente, Matthew; Birrer, Michael J.; Liang, Sharon X. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer EDITORIAL COMMENT. Obstetrical & gynecological survey. 2012, 67(5):289-290.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
0029-7828
1533-9866
1533-9866